Genoway SA
PAR:ALGEN
Genoway SA
Cash & Cash Equivalents
Genoway SA
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Genoway SA
PAR:ALGEN
|
Cash & Cash Equivalents
€4.9m
|
CAGR 3-Years
21%
|
CAGR 5-Years
55%
|
CAGR 10-Years
3%
|
||
Valneva SE
PAR:VLA
|
Cash & Cash Equivalents
€131.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Innate Pharma SA
PAR:IPH
|
Cash & Cash Equivalents
€70m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-1%
|
||
G
|
Genfit SA
PAR:GNFT
|
Cash & Cash Equivalents
€61.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-1%
|
|
Inventiva SA
PAR:IVA
|
Cash & Cash Equivalents
€10.1m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
||
Eurobio Scientific SA
PAR:ALERS
|
Cash & Cash Equivalents
€86.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
61%
|
CAGR 10-Years
19%
|
Genoway SA
Glance View
genOway SA engages in the development of genetically-modified mouse, rat, and cellular models for biopharmaceutical and research companies. The company is headquartered in Lyon, Auvergne-Rhone-Alpes. The company went IPO on 2007-05-04. The firm offers an array of services which include site specific transgenesis, random insertion based transgenic models, gene overexpression, humanization, gene deletion and gene knock-down (RNA interference). The Company’s clients include multinational biopharmaceutical companies, such as Roche, Novartis and Servier, as well as universities and research institutes, notably Boston University, University of Tokyo, Johann Wolfgang Goethe University Hospital Frankfurt and Centre National de Genotypage.
See Also
What is Genoway SA's Cash & Cash Equivalents?
Cash & Cash Equivalents
4.9m
EUR
Based on the financial report for Jun 30, 2024, Genoway SA's Cash & Cash Equivalents amounts to 4.9m EUR.
What is Genoway SA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
3%
Over the last year, the Cash & Cash Equivalents growth was 73%. The average annual Cash & Cash Equivalents growth rates for Genoway SA have been 21% over the past three years , 55% over the past five years , and 3% over the past ten years .